PGNY

Progyny, Inc. · NASDAQ

Sector Commercial Services
Industry Miscellaneous Commercial Services
Website rogyny.com
Employees(FY) 393
ISIN US74340E1038

Performance

-3.5%

+4.9%

-12.88%

-44.27%

-61.43%

YTD

-60.57%

Profile

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Advanced Technical Analysis

Technical Analysis of PGNY 2024-12-20

The stock indicators reflect a bearish sentiment overall, with a Moving Average Score of 10 indicating strong downward pressure, while the Oscillators Score of 53 suggests a neutral stance. The Technical Score of 31 further reinforces the bearish outlook, indicating that caution is warranted in the current market environment.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of PGNY

Stock Rank

Recent News & Updates

2024-12-18 07:33
PGNY Stockholders: Robbins LLP is Investigating the Officers and Directors of Progyny, Inc. to Determine if They Breached Fiduciary Duties Owed to Shareholders(Prnewswire)
2024-12-17 19:00
PGNY: Lowering target price to $12.00(Argus Research)
2024-12-11 09:38
Robbins LLP Informs Progyny, Inc. Stockholders that it is Investigating the Officers and Directors of PGNY to Determine if They Breached Fiduciary Duties Owed to Shareholders(Globenewswire)
2024-12-10 19:00
PGNY: Raising target price to $13.00(Argus Research)
2024-12-05 05:47
What Does Progyny, Inc.'s (NASDAQ:PGNY) Share Price Indicate?(Simply Wall St.)
2024-12-03 19:00
PGNY: What does Argus have to say about PGNY?(Argus Research)
2024-12-02 13:38
Here’s What Led to a Sharp Drop in Progyny’s (PGNY) Share Price(Insider Monkey)
2024-12-02 09:03
JPMorgan Downgrades Progyny to Neutral, Price Target is $17(MT Newswires)
2024-11-29 09:59
Meridian Hedged Equity Fund Decided to Sell its Holdings in Progyny (PGNY). Here’s Why(Insider Monkey)
2024-11-26 19:00
PGNY: Raising target price to $12.00(Argus Research)
2024-11-18 09:08
Here’s Why Progyny (PGNY) Was Under Pressure in Q3(Insider Monkey)
2024-11-14 09:00
Progyny, Inc. to Present at Jefferies London Healthcare Conference(GlobeNewswire)
2024-11-14 06:48
Progyny Third Quarter 2024 Earnings: Misses Expectations(Simply Wall St.)
2024-11-14 06:45
Progyny price target lowered to $21 from $22 at BofA(TipRanks)
2024-11-13 20:00
Progyny, Inc. to Present at Jefferies London Healthcare Conference(Globenewswire)
2024-11-13 16:40
Why Progyny Stock Crashed Today(Motley Fool)
2024-11-13 12:42
Jefferies Adjusts Progyny Price Target to $19 From $24, Maintains Buy Rating(MT Newswires)
2024-11-13 09:14
Sector Update: Health Care Stocks Rise Premarket Wednesday(MT Newswires)
2024-11-13 08:52
Sector Update: Health Care(MT Newswires)
2024-11-13 06:32
Truist Downgrades Progyny to Hold From Buy, Cuts Price Target to $19 From $26(MT Newswires)
2024-11-13 04:36
Progyny Q3 Adjusted Earnings, Revenue Increase; 2024 Revenue Guidance Cut(MT Newswires)
2024-11-13 02:19
Progyny Inc (PGNY) Q3 2024 Earnings Call Highlights: Strong Client Growth Amid Utilization ...(GuruFocus.com)
2024-11-12 17:35
Progyny (PGNY) Tops Q3 Earnings Estimates(Zacks)
2024-11-12 16:30
Progyny: Q3 Earnings Snapshot(Associated Press Finance)
2024-11-12 16:02
Progyny, Inc. Announces Third Quarter 2024 Results(GlobeNewswire)
2024-11-12 03:02
Progyny, Inc. Announces Third Quarter 2024 Results(Globenewswire)
2024-11-11 07:10
Progyny Inc (PGNY) Q3 2024 Earnings Report Preview: What to Look For(GuruFocus.com)
2024-11-09 09:09
Progyny (NASDAQ:PGNY) Might Be Having Difficulty Using Its Capital Effectively(Simply Wall St.)
2024-11-07 20:20
Progyny (PGNY) Client Retention Narrative Under Examination - Hagens Berman(Globenewswire)
2024-11-06 18:15
ModivCare (MODV) Q3 Earnings and Revenues Lag Estimates(Zacks)

Page 1 of 10

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.